May 21, 2021 4:45pm EDT 180 Life Sciences Corp. Receives Expected Notification From Nasdaq Related To Delayed Quarterly Report on Form 10-Q
Apr 20, 2021 8:00am EDT 180 Life Sciences Corp. Announces Collection of All Patient Data for Phase 2b Dupuytren’s Disease Trial
Apr 19, 2021 5:00pm EDT 180 Life Sciences Corp. Receives Expected Notification From Nasdaq Related To Delayed Annual Report on Form 10-K
Apr 14, 2021 8:15am EDT 180 Life Sciences Corp. Congratulates Dr. Lynn Williams on International Dupuytren Award 2021
Mar 26, 2021 8:30am EDT 180 Life Sciences Corp. (NASDAQ: ATNF) Recognized R&D Pioneers in Anti-Inflammatory Therapeutics
Mar 25, 2021 8:30am EDT 180 Life Sciences Corp. (NASDAQ: ATNF) in Hot Pursuit of New Anti-Inflammatory Blockbusters
Mar 24, 2021 8:30am EDT 180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders
Mar 08, 2021 1:30pm EST 180 Life Sciences Corp. to Present at Inaugural Emerging Growth Virtual Conference, presented by M Vest LLC and Maxim Group LLC